Clinical Trial

Effects of E-Cigarette Use on Oxidative Stress and Matrix Degradation

Study acronym: ECIG-FOXO
Completed
View on ClinicalTrials.gov →
Summary
This cross-sectional observational study aims to investigate the effects of e-cigarette use on oxidative and matrix-degrading pathways in periodontally healthy individuals. Gingival crevicular fluid biomarkers, including matrix metalloproteinase-9 (MMP-9), reactive oxygen species (ROS), and forkhead-box-1 (FOXO1), will be analyzed to compare the biochemical and inflammatory responses among three groups: e-cigarette users, conventional cigarette smokers, and non-smokers. The study seeks to clarify whether e-cigarette use induces subclinical inflammatory or proteolytic activity in oral tissues comparable to that of traditional smoking.
Trial Details
NCT Number NCT07338318
Lead Sponsor Ankara Medipol University
Conditions Smoking Behaviors, Periodontal Health
Enrollment 60 participants
Start Date 2025-04-30
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-13